Direct Fluconazole Disk Susceptibility Testing for Candida glabrata-Positive Blood Cultures.
Candida glabrata
direct disk susceptibility testing
fluconazole
Journal
Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564
Informations de publication
Date de publication:
18 06 2021
18 06 2021
Historique:
pubmed:
23
4
2021
medline:
29
6
2021
entrez:
22
4
2021
Statut:
ppublish
Résumé
Direct susceptibility testing from blood cultures has been reported to reduce the time interval between a positive blood culture to preliminary reporting of susceptibility and can underpin timely appropriate treatment of candidemia. The aim of this study was to evaluate direct susceptibility testing of Candida glabrata to fluconazole using disk diffusion compared to the Sensititre YeastOne broth microdilution-based method. We tested 83 isolates recovered from 93 spiked and prospective blood culture bottles. Comparison of the two methods showed excellent agreement, with no very major errors and only two major errors (2.4%). The accuracy of the fluconazole disk method was 97.6% (95% confidence interval [CI], 91.6 to 99.7), with a sensitivity of 100% (95% CI, 82.3 to 100) and a specificity of 96.9% (95% CI, 89.2 to 99.6). Direct antifungal disk susceptibility testing from blood cultures is a rapid and easy-to-perform method to determine fluconazole susceptibility of C. glabrata isolates and can be used safely to reduce susceptibility report time and improve clinical decision making regarding appropriate treatment.
Identifiants
pubmed: 33883184
pii: JCM.00311-21
doi: 10.1128/JCM.00311-21
pmc: PMC8218755
doi:
Substances chimiques
Antifungal Agents
0
Fluconazole
8VZV102JFY
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0031121Références
Eur J Clin Microbiol Infect Dis. 2017 Jan;36(1):131-137
pubmed: 27677278
Antimicrob Agents Chemother. 2017 Jun 27;61(7):
pubmed: 28483951
Antimicrob Agents Chemother. 2015 Jul;59(7):3944-55
pubmed: 25896705
J Clin Microbiol. 2011 Aug;49(8):2879-83
pubmed: 21677065
J Clin Microbiol. 2004 Feb;42(2):718-21
pubmed: 14766842
Clin Microbiol Infect. 2019 Jul;25(7):792-798
pubmed: 30965100
J Clin Microbiol. 2004 Oct;42(10):4577-80
pubmed: 15472311
Antimicrob Agents Chemother. 2005 Sep;49(9):3640-5
pubmed: 16127033
J Clin Microbiol. 2005 Apr;43(4):1727-31
pubmed: 15814992
Mycoses. 2008 May;51(3):200-4
pubmed: 18399900
Antimicrob Agents Chemother. 2010 Jan;54(1):184-90
pubmed: 19884371
J Clin Microbiol. 2010 Apr;48(4):1366-77
pubmed: 20164282
J Clin Microbiol. 2016 Feb;54(2):343-8
pubmed: 26607985
Clin Microbiol Infect. 2012 Dec;18 Suppl 7:19-37
pubmed: 23137135
Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S79-S94
pubmed: 30895218
PLoS One. 2014 Dec 09;9(12):e114834
pubmed: 25489741
Front Cell Infect Microbiol. 2019 Oct 11;9:352
pubmed: 31681629
New Microbiol. 2009 Apr;32(2):179-84
pubmed: 19579696
Clin Infect Dis. 2016 Feb 15;62(4):e1-50
pubmed: 26679628
J Clin Microbiol. 2001 Apr;39(4):1328-33
pubmed: 11283051
Diagn Microbiol Infect Dis. 2008 Mar;60(3):273-7
pubmed: 18024053
J Clin Microbiol. 2010 Jun;48(6):2205-12
pubmed: 20392904